{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:54:29Z","timestamp":1793386469278,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s40261-019-00858-6","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T21:35:45Z","timestamp":1569879345000},"page":"1045-1056","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Efficacy and Safety of a Fixed Combination of Cinnarizine 20\u00a0mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16\u00a0mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial"],"prefix":"10.1007","volume":"39","author":[{"given":"Arne W.","family":"Scholtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdana","family":"Stefflova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Medzhidieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Ryazantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Paschinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kunelskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Weisshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"858_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-85729-591-0","volume-title":"Vertigo and dizziness\u2014common complaints","author":"T Brandt","year":"2013","unstructured":"Brandt T, Dieterich M, Strupp M. Vertigo and dizziness\u2014common complaints. 2nd ed. London: Springer; 2013.","edition":"2"},{"key":"858_CR2","first-page":"2","volume":"16","author":"LE Walther","year":"2017","unstructured":"Walther LE. Current diagnostic procedures for diagnosing vertigo and dizziness. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017;16:2.","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg."},{"issue":"6","key":"858_CR3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1212\/01.wnl.0000175987.59991.3d","volume":"65","author":"HK Neuhauser","year":"2005","unstructured":"Neuhauser HK, von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology. 2005;65(6):898\u2013904.","journal-title":"Neurology"},{"issue":"19","key":"858_CR4","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1001\/archinte.168.19.2118","volume":"168","author":"HK Neuhauser","year":"2008","unstructured":"Neuhauser HK, Radtke A, von Brevern M, Lezius F, Feldmann M, Lempert T. Burden of dizziness and vertigo in the community. Arch Intern Med. 2008;168(19):2118\u201324.","journal-title":"Arch Intern Med."},{"key":"858_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1055\/s-0029-1241043","volume":"29","author":"HK Neuhauser","year":"2009","unstructured":"Neuhauser HK, Lempert T. Vertigo: epidemiologic aspects. Semin Neurol. 2009;29:473\u201381.","journal-title":"Semin Neurol"},{"issue":"10","key":"858_CR6","first-page":"173","volume":"105","author":"M Strupp","year":"2008","unstructured":"Strupp M, Brandt T. Diagnosis and treatment of vertigo and dizziness. Dtsch Arztebl Int. 2008;105(10):173\u201380.","journal-title":"Dtsch Arztebl Int."},{"key":"858_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/WCO.0b013e32835c5fd4","volume":"26","author":"M Strupp","year":"2013","unstructured":"Strupp M, Brandt T. Peripheral vestibular disorders. Curr Opin Neurol. 2013;26:81\u20139.","journal-title":"Curr Opin Neurol."},{"issue":"5","key":"858_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.zefq.2008.05.001","volume":"102","author":"Carsten Kruschinski","year":"2008","unstructured":"Kruschinski C, Kersting M, Breull A, Kochen MM, Koschack J, Hummers-Pradier E. Frequency of dizziness-related diagnoses and prescriptions in a general practice database. Z Evid Fortbild Qual Gesundh wesen. 2008;102:313\u2013319 (Article in German). \nhttps:\/\/doi.org\/10.1016\/j.zefq.2008.05.001\n\n.","journal-title":"Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen"},{"key":"858_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2296-11-2","volume":"11","author":"OR Maarsingh","year":"2010","unstructured":"Maarsingh OR, Dros J, Schellevis FG, Van Weert HC, Bindels PJ, van der Horst HE. Dizziness reported by elderly patients in family practice: prevalence, incidence, and clinical characteristics. BMC Family Practice. 2010;11:2.","journal-title":"BMC Family Practice."},{"issue":"48","key":"858_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2013.00048","volume":"4","author":"S Agus","year":"2013","unstructured":"Agus S, Benecke H, Thum C, Strupp M. Clinical and demographic features of vertigo: findings from the REVERT registry. Front Neurol. 2013;4(48):1\u20138. \nhttps:\/\/doi.org\/10.3389\/fneur.2013.00048\n\n.","journal-title":"Front Neurol"},{"key":"858_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/VES-130496","volume":"23","author":"M Lacour","year":"2013","unstructured":"Lacour M. Betahistine treatment in managing vertigo and improving vestibular compensation: clarification. J Vestib Res. 2013;23:139\u201351.","journal-title":"J Vestib Res."},{"key":"858_CR12","first-page":"208","volume":"26","author":"C Della Pepa","year":"2006","unstructured":"Della Pepa C, Guidetti G, Eandi M. Betahistine in the treatment of vertiginous syndromes: a meta-analysis. Acta Otorhinolaryngol Ital. 2006;26:208\u201315.","journal-title":"Acta Otorhinolaryngol Ital."},{"issue":"5","key":"858_CR13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00405-013-2596-8","volume":"271","author":"JJ Nauta","year":"2014","unstructured":"Nauta JJ. Meta-analysis of clinical studies with betahistine in M\u00e9ni\u00e8re\u2019s disease and vestibular vertigo. Eur Arch Otorhinolaryngol. 2014;271(5):887\u201397.","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"858_CR14","doi-asserted-by":"publisher","unstructured":"Murdin L, Hussain K, Schilder AGM. Betahistine for symptoms of vertigo. Cochrane Database Syst Rev 2016; 6: CD010696. \nhttps:\/\/doi.org\/10.1002\/14651858.cd010696.pub2\n\n.","DOI":"10.1002\/14651858.cd010696.pub2"},{"key":"858_CR15","first-page":"27","volume":"18","author":"T Godfraind","year":"1982","unstructured":"Godfraind T, Towse G, Van Nueten JM. Cinnarizine: a selective calcium entry blocker. Drugs Today. 1982;18:27\u201342.","journal-title":"Drugs Today."},{"key":"858_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00210-004-0936-3","volume":"369","author":"SF Arab","year":"2004","unstructured":"Arab SF, D\u00fcwel P, J\u00fcngling E, Westhofen M, L\u00fcckhoff A. Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine. Naunyn Schmiedebergs Arch Pharmacol. 2004;369:570\u20135.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"858_CR17","first-page":"718","volume":"176","author":"BP Jaju","year":"1971","unstructured":"Jaju BP, Wang SC. Effects of diphenhydramine and dimenhydrinate on vestibular neuronal activity of cat: a search for the locus of their antimotion sickness action. J Pharmacol Exp Ther. 1971;176:718\u201324.","journal-title":"J Pharmacol Exp Ther."},{"key":"858_CR18","unstructured":"Dollery C. Therapeutic Drugs. Second edition. Churchill Livingstone; 1999. Vol. 1, Diphenhydramine D152\u201356."},{"key":"858_CR19","unstructured":"Kessler L, Bognar-Steinberg I, Baumann W, Skurczynski W. Treatment of vestibular vertigo: comparison of a fixed combination of cinnarizine 20mg and dimenhydrinate 40mg with the 2.5-fold higher dosed active drugs in monotherapy. A prospective, randomized, reference-controlled, two-center, double-blind study. Arch Sensol Neurootol Sci Pract. 2012;7:1\u201313."},{"issue":"1","key":"858_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clinthera.2007.01.010","volume":"29","author":"J Pytel","year":"2007","unstructured":"Pytel J, Nagy G, Toth A, Spellenberg S, Schwarz M, Repassy G. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study. Clin Ther. 2007;29(1):84\u201398.","journal-title":"Clin Ther."},{"key":"858_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2165\/00044011-200525060-00003","volume":"25","author":"Z Cirek","year":"2005","unstructured":"Cirek Z, Schwarz M, Baumann W, Novotn\u00fd M. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate versus betahistine in the treatment of otogenic vertigo. A double-blind, randomized clinical study. Clin Drug Investig. 2005;25:377\u201389.","journal-title":"Clin Drug Investig."},{"key":"858_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0149-2918(04)90130-0","volume":"26","author":"AW Scholtz","year":"2004","unstructured":"Scholtz AW, Schwarz M, Baumann W, Kleinfeldt D, Scholtz HJ. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study. Clin Ther. 2004;26:866\u201377.","journal-title":"Clin Ther."},{"key":"858_CR23","first-page":"57","volume":"14","author":"V Otto","year":"2008","unstructured":"Otto V, Fischer B, Schwarz M, Baumann W, Preibisch-Effenberger R. Treatment of vertebrobasilar insufficiency-associated vertigo with a fixed combination of cinnarizine and dimenhydrinate. Int Tinnitus J. 2008;14:57\u201367.","journal-title":"Int Tinnitus J."},{"key":"858_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2165\/00044011-200828020-00003","volume":"28","author":"A Hahn","year":"2008","unstructured":"Hahn A, Sejna I, Stefflova B, Schwarz M, Baumann W. A fixed combination of cinnarizine\/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders. A randomized, reference-controlled, clinical study. Clin Drug Investig. 2008;28:89\u201399.","journal-title":"Clin Drug Investig."},{"issue":"6","key":"858_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2165\/11588920-000000000-00000","volume":"31","author":"A Hahn","year":"2011","unstructured":"Hahn A, Novotn\u00fd M, Shotekov PM, Cirek Z, Bognar-Steinberg I, Baumann W. Comparison of cinnarizine\/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins. Clin Drug Investig. 2011;31(6):371\u201383.","journal-title":"Clin Drug Investig."},{"issue":"6","key":"858_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2165\/11632410-000000000-00000","volume":"32","author":"AW Scholtz","year":"2012","unstructured":"Scholtz AW, Steindl R, Burchardi N, Bognar-Steinberg I, Baumann W. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis. A randomized, double-blind, non-inferiority study. Clin Drug Investig. 2012;32(6):387\u201399.","journal-title":"Clin Drug Investig."},{"key":"858_CR27","first-page":"115","volume":"8","author":"M Novotn\u00fd","year":"2002","unstructured":"Novotn\u00fd M, Kostrica R. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Meni\u00e8re\u2019s disease: a randomized, double-blind, parallel-group clinical study. Int Tinnitus J. 2002;8:115\u201323.","journal-title":"Int Tinnitus J."},{"key":"858_CR28","unstructured":"Novotn\u00fd M, Bognar-Steinberg I, Baumann W. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Meni\u00e8re\u2019s disease: post hoc non-inferiority analysis of a prospective, randomized, double-blind study. Arch Sensol Neurootol-ASN. 2011:6 [online]. \nhttps:\/\/neurootology.org\/archives\/649\n\n. Accessed 13 May 2019."},{"issue":"5","key":"858_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2165\/00044011-199918050-00003","volume":"18","author":"D Schremmer","year":"1999","unstructured":"Schremmer D, Bognar-Steinberg I, Baumann W, Pytel J. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate in treatment of vertigo: analysis of data from five randomized, double-blind clinical studies. Clin Drug Invest. 1999;18(5):355\u201368.","journal-title":"Clin Drug Invest."},{"key":"858_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407\u201315.","journal-title":"Control Clin Trials."},{"key":"858_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","volume":"47","author":"EF Juniper","year":"1997","unstructured":"Juniper EF, Guyatt GH, William A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1997;47:81\u20137.","journal-title":"J Clin Epidemiol."},{"key":"858_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139\u201344.","journal-title":"J Clin Oncol."},{"key":"858_CR33","unstructured":"FDA Guidance for Industry. Non-inferiority clinical trials to establish effectiveness. 2016. \nhttps:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/non-inferiority-clinical-trials.15546fnl.pdf\n\n. Accessed 4 Sep 2019."},{"key":"858_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0022215100146158","volume":"98","author":"WJ Oosterveld","year":"1984","unstructured":"Oosterveld WJ. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin: a double-blind placebo controlled study. J Laryngol Otol. 1984;98:37\u201341.","journal-title":"J Laryngol Otol."},{"key":"858_CR35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00405-002-0524-4","volume":"260","author":"E Mira","year":"2003","unstructured":"Mira E, Guidetti G, Ghilardi PL, Fattori B, Malannino N, Maiolino L, et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol. 2003;260:73\u20137.","journal-title":"Eur Arch Otorhinolaryngol."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-019-00858-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-019-00858-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-019-00858-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T19:26:47Z","timestamp":1601321207000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-019-00858-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["858"],"URL":"https:\/\/doi.org\/10.1007\/s40261-019-00858-6","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,30]]},"assertion":[{"value":"30 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was funded by Hennig Arzneimittel, Fl\u00f6rsheim am Main, Germany and Berlin-Chemie AG\/Menarini, Berlin, Germany. Berlin-Chemie AG\/Menarini funded the open-access fee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Arne W. Scholtz, Ales Hahn, Bohdana Stefflova, Daniela Mezhidieva, Sergey V. Ryazantsev, Alexander Paschinin and Natalia Kunelskaya have no conflicts of interest that are directly relevant to the content of this article. Kai Schumacher is an employee of Berlin-Chemie AG\/Menarini and Gerhard Weisshaar is an employee of Hennig Arzneimittel.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the ICH guidelines for Good Clinical Practice (GCP) and the Declaration of Helsinki in its current version following approvals by the Ethics Committees of all institutions involved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual study participants prior to enrollment in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}